|
|
| Home | Speakers | Programme | The Venue | Delegates | Sponsors | Media | Register |
  |
Sponsors  Synergy Research
Group (SynRG™) is a leading Russian Contract Research
Organization (CRO) successfully assisting
pharmaceutical and biotechnology companies, as well as
global CROs in conducting clinical trials in Russia
and the Commonwealth of Independent States (CIS) since
2002.
SynRG was established as an answer to the growing demand for clinical trials in Eastern Europe. We are committed to provide high quality services capitalizing on our in-depth knowledge of international and local regulations, long-term relationships with central and peripheral medical institutions, and a broad network of investigators with vast clinical research experience in various therapeutic areas. SynRG is a client-oriented company with emphasis on true partnership relations with the client. Our collaborative effort is based on a mutual respect for one another's expertise, knowledge, and skills; through close cooperation we eliminate territorial issues, communicate efficiently and work proactively among team members to ensure success of the project. With SynRG you will feel like our only client!  MakroCare is a Drug Development and Commercialization Partner to Pharmaceutical, Biotechnology and Medical Device industries providing a full range of customized services with teams positioned in USA, Europe, India, China, Singapore and Japan. MakroCare divisions include CRO, SMO, Clinical Informatics, Consulting and Commercialization. An ISO 9001, 27001, 20000 Certified company. Our dedicated focus to Oncology, CNS and Cardiovascular and our in-depth understanding of these fields has enabled us to provide comprehensive services to our clients. The therapeutic area specialization means that our operations are optimized to work efficiently in these challenging areas. Whether it’s a full service need from strategic planning to study conduct to close out or specific functional services, MakroCare has in-depth experience and expertise to match your needs and goals. Our extensive worldwide contacts and involvement with the research community keep us close to research trends and developments. Our management team, project managers and medical advisors have deep experience to complement their skills in operational and technical matters. From our Site and Patient enrolment division, we help site identification, selection, patient enrolment/retention and media management. As clinical studies’ success, especially for Oncology, mainly lies on proper patient enrolment, we help right from country selection to site/PI selection to putting site specific enrolment plans for meeting budget and timeline goals of sponsors. Our highly experienced clinical research professionals are able to fulfil the most challenging clinical programs. We have a clear understanding of clinical research requirements on a global and local country level and have established excellent global project management that ensures meeting of deliverables and milestones.  At Eurofins Global
Central Laboratory, laboratory science is our sole
focus. With over 20 years of experience and scientific
expertise, we utilize our global central laboratories to
continually attain the most cost effective and efficient
solutions for your clinical trial needs. We are
dedicated to providing all laboratory testing needed in
clinical trials and have developed one of the broadest
testing portfolios available in the pharmaceutical
industry today. By combining all laboratory testing in
one project, we offer synergetic benefits with regard to
turnaround time of results, harmonized procedures,
logistics and reporting.
Eurofins Global Central Laboratory supports its customers with 6 wholly-owned facilities in the United States, Europe, India, Singapore and China. With three central laboratories operating in the Asia-Pacific region, Eurofins Global Central Laboratory is considered as one of the top central laboratory organizations in the world. If required, we extend our global coverage through standardized local central laboratory partners to reduce costs, accelerate logistic time-lines, or to accommodate local needs for a given study. Dedication you can rely on.  ORION Clinical
Services is a full service CRO focussing on oncology.
With offices in UK, Germany, France, Italy, Australia
and the USA - we manage studies in more than 20
territories globally. We combine global
capabilities with the quality, customer focus and
cost-effectiveness that you would associate with the
best niche CROs.
 ClinStar is a leading CRO in emerging markets with extraordinarily fast patient enrollment, higher quality and passion for customer service. ClinStar, headquartered in San Francisco, California, is a contract research organization (CRO) that manages Phase I-IV clinical research trials in Russia, Ukraine, Belarus and the Baltic States. We are one of the oldest and most well established CROs in our region with more than 250 professionals based in our offices in Moscow, St. Petersburg, Kiev and Minsk, as well as regionally throughout Russia and other parts of Eastern Europe. From start-up and regulatory submissions to clinical monitoring, safety and medical services to drug storage and distribution, we offer fully integrated services for managing your trials throughout Russia, Ukraine and other regions of Eastern Europe. ClinStar-monitored data from Russian and Ukrainian clinical trials has been included in several FDA and EMEA submissions and approvals. Since ClinStar is consistently a top enroller in the studies in which we participate, we are one of the most audited CROs in the world. Our audit results have always been positive with no critical findings. Combining a progressive western management style with Russian and Ukrainian quality, work ethics and patient recruitment rates has resulted in ClinStar becoming a leading CRO in this emerging region.  As one of the most innovative and scientifically-driven contract research organizations, Worldwide Clinical Trials offers clients an exceptionally strong therapeutic focus with an equally strong and effective network of global operations. Worldwide Clinical Trials specializes in providing drug development services in CNS, cardiovascular disease, chronic inflammatory disease, and oncology to the pharmaceutical and biotechnology industries. Within the cardiovascular clinical research arena we are leaders with over 20 years of experience in cardiovascular indications and particular expertise in executing large, global outcomes studies. Added to a history of working with key opinion leaders such as the Thrombolysis in Myocardial Infarction Institute (TIMI) and Duke Clinical Research Institute (DCRI), and sponsors can be assured of achieving impeccable and statistically relevant data. Medically &
Scientifically Driven Clinical Research
Global Reach: Worldwide Depth Integrated Technology Solutions  Aptiv Solutions
is a global biopharmaceutical and medical device
development services company focused on recognizing,
understanding and enabling clients to capitalize on
rapid and fundamental changes facing companies
developing products in the pharmaceutical, biotech and
medical device market. The company offers clients an
extensive portfolio of innovative services including
adaptive clinical trials, early phase product
strategy, regulatory services, pharmacovigilance,
clinical staffing and the operational support of a
global clinical research organization. Aptiv
Solutions has over 850 professionals in North America,
Europe, the Middle East, Japan, and Australia, and
operates out of 29 offices in 17 countries.
Aptiv Solutions is the only CRO to offer design, simulation and execution of adaptive clinical trials – and the only CRO to make fully functional clinical trials a reality. In the last 10 years, we have managed over 100 adaptive clinical trials. In addition, we have developed the industry leading software ADDPLAN™, to manage adaptive trial design, simulation and sample-size re-calculation. For more information, please visit our website at www.aptivsolutions.com  Pharm-OIam International is a full service, clinical CRO that provides Phase I-IV research services with offices worldwide, 450 employees and coverage in over 40 countries. Our offices are among the most populated cities in Europe, Latin America, India, South Africa, the Philippines, and North America to provide cost effective coverage for Oncology and Cardiovascular studies of all sizes. We have helped bring 14 compounds to marketing approval (EMA and US FDA) including Oncology and Cardiovascular drugs. Globally our CRAs average over 6 years of monitoring experience. In emerging markets the majority of our clinical staff are MDs, Pharmacists, or have PhDs in science. We also have Oncologists and Cardiologists in both clinical and pharmacovigilance departments. Pharm-Olam has exceptional coverage in Eastern Europe, including Russia, Ukraine, Belarus, Georgia, and Kazakhstan. In these nations we have our own drug storage and employee managed logistics teams along with full time regulatory experts to meet the more challenging requirements for import of study supplies. Sponsors can contact Pharm-Olam for a complimentary feasibility study based on their protocol requirements to determine the best areas for research. Please also visit www.Pharm-Olam.com for more information and to view an interactive map containing estimated incidence rates for all major cancer types. Services offered include: Patient Recruitment, Monitoring, Pharmacovigilance (including EudraVigilance), Feasibility Studies, Data Management, Biostatistics, Protocol Design, Investigator Identification, Ethics Committee & Regulatory Submissions, Import/Export Licenses, DSMB Preparation, Project Management, Quality Control, Quality Assurance, Product Registration, CTMS, Medical Writing, Translations, CRF Design, Investigator Meetings, Health-Outcomes Research, Registry Studies, Staff Training, and Post-Marketing Surveillance. ‘I have worked with many large and small CROs over the years and would highly recommend POI for any project of any complexity’ Sponsor COO / VP Clinical Operations  Altiora based in
Zagreb, Croatia and founded in April 2001, is a Contract
Research Organization (CRO) that operates in Central and
Eastern EU having offices in UK, Poland, Croatia,
Hungary, Bosnia and Herzegovina, Macedonia and
Serbia. We conduct Phase I - IV clinical trials
for global pharmaceutical and biotechnology firms and
provide a wide range of related services. We are
experienced in implementing and conforming to the SOP’s
of various worldwide drug companies and add value by
meeting the evolving, complex needs of today’s clinical
development organizations.
Altiora's staff is a small but highly educated, knowledgeable and experienced group of healthcare professionals, all with medical backgrounds. The staff has strong relationships with key stakeholders such as regulatory authorities, principal investigators, regional opinion leaders and site study staff. We are highly motivated, operate in a team-based environment and committed to adding value, meeting clients’ needs and exemplifying both the small & large company attributes of Altiora. Altiora offers the agility of a small firm with a dedication to customer service and cost-effectiveness but with the knowledge, experience, quality and performance akin to a large firm, enabling the provision of highest quality services! Altiora is involved in studies across various therapeutic areas, in many different indications, in different phases of development (I-IV) and in various sizes relative to numbers of sites and patients. We are poised to expand as demand for our services increases.  CoreLab Partners is
a leading, independent core lab providing best in class
centralized cardiac safety services and medical imaging
assessment solutions for pharmaceutical, biotechnology,
and medical device sponsors of Phase I-IV studies. Our
commitment to service quality and scientific excellence
is focused on expediting our clients’ drug development
program.
CoreLab Partners is committed to providing unparalleled service quality, dedicated global capabilities and advanced technologies to improve efficiency, reduce costs and shorten timelines associated with clinical research programs. By combining proven operational processes, experienced project teams and full-time, board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists, we deliver accurate, credible trial data on-time and on-budget. Our comprehensive suite of cost effective solutions have supported greater than 750+ studies across a broad range of imaging modalities, cardiac safety services and therapeutic indications. Further, our market leading medical imaging services are proven across more oncology trials than any other core laboratory. CoreLab Partners’ global footprint comprises more than 325 employees and offices with operational capabilities in North America, Europe and Asia.  EastHORN Clinical Services in CEE is a full service pI – IV clinical research organisation specialising in Central & Eastern Europe providing coverage across the region. The company’s roots were established in 2004 in Prague and since then have organically grown and spread East across the region as far as Russia and Georgia and now employs over 100 people; many of which hold MDs and specialise in different therapy areas EastHORN boasts a highly experienced senior management team who have held senior positions in major global CROs but have brought this knowledge to a major regional provider. EastHORN prides itself in delivery and as a consequence repeat business forms a large part of EastHORN’s project portfolio and clients range from top 3 pharma to virtual biotechs and medical device companies. Oncology and Cardiology are the two therapy areas in which EastHORN has the most experience. For this meeting EastHORN has brought an expert to attend each stream. Dr Robert Kurowicki EastHORN’s feasibility manager has a great deal of experience in Oncology and Dr Ales Horacek who is EastHORN’s Chief Operating Officer and a Cardiologist by training. Please feel free to approach either during the meeting with any questions regarding clinical trials in CEE. Dr. Alan Wood – Chairman of EastHORN will be chairing conference sessions. He has 30 years experience in pharmaceutical research and development, both in pharmaceutical companies and in CROs. Most recently, he was Senior Director, R&D Operations at NicOx SA, a French biotechnology company. Previously, Dr. Wood was General Manager, Europe and Asia-Pacific at Covance and prior to that at Quintiles in different business development and general management roles. He started his clinical development career with Sandoz (now Novartis) in Switzerland. Dr Wood graduated in pharmacy and pharmacology from the University of Otago, New Zealand. "Global
Engage are well organised, professional and very
attentive to needs. I enjoyed the quality of
delegates that are attracted to this event".
Director, International Sales, CoreLab Partners “Very good.
The prearranged nature of the meetings was
excellent”
President, i3 Research “The meetings you provided were brilliant. This was an excellent way to discuss business. I have several leads and an excellent opportunity has presented itself. Thank you once again, and I thoroughly recommend Global Engage's events” Eric Hilton, Business Development Director Food & Drug Analytical Services Ltd. For further details please contact Steve Hambrook (Conference Director). Telephone +44 (0) 1865 811 189 or email steve@globalengage.co.uk |
 Media Partners
 |
|
Copyright: Global Engage Ltd.
Registered in England. No: 6950636 |